Alle verbonden artikelen

Liquid biopsy: will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies?

Auteurs : Gingras I, Salgado R, Ignatiadis M
Jaar : 2015
Journal : Curr Opin Oncol
Volume : 27
Pagina's : 560-7

A first-in-human phase I and pharmacokinetic study of CP-4126 (CO-101), a nucleoside analogue, in patients with advanced solid tumours.

Auteurs : Venugopal B, Awada A, Evans TR, Dueland S, Hendlisz A, Rasch W, Hernes K, Hagen S, Aamdal S
Jaar : 2015
Journal : Cancer Chemother Pharmacol
Volume : 76(4)
Pagina's : 785-92

Colorectal cancer: ten years of illusion of progress but advances are on the horizon].

Auteurs : Shaza L, Charette N, Hendlisz A
Jaar : 2015
Journal : Rev Med Brux
Volume : 36
Pagina's : 263-6

Erdheim-Chester Disease: A Case Report.

Auteurs : Alexiou J, Klastersky J
Jaar : 2015
Journal : Am J Case Rep
Volume : 16
Pagina's : 361-6

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol.

Auteurs : Hendlisz A, Deleporte A, Vandeputte C, Charette N, Paesmans M, Guiot T, Garcia C, Flamen P
Jaar : 2015
Journal : BMJ Open
Volume : 5(3)
Pagina's : e007189

Prophylaxis of febrile neutropenia in adults receiving chemotherapy needs to be adapted to the risk.

Auteurs : Georgala A, Klastersky J
Jaar : 2015
Journal : Expert Rev Hematol
Volume : 8(1)
Pagina's : 115-21

An update on PARP inhibitors-moving to the adjuvant setting.

Auteurs : Sonnenblick A, de Azambuja E, Azim HA, Piccart-Gebhart M
Jaar : 2015
Journal : Nat Rev Clin Oncol
Volume : 12(1)
Pagina's : 27-41

Phase I trial of volasertib, a Polo-like kinase inhibitor, plus platinum agents in solid tumors: safety, pharmacokinetics and activity.

Auteurs : Awada A, Dumez H, Aftimos P, Costermans J, Bartholomeus S, Forceville K, Berghmans T, Meeus MA, Cescutti J, Munzert G, Pilz K, Liu D, Schöffski P
Jaar : 2015
Journal : Invest New Drugs
Volume : 33(3)
Pagina's : 611-20

Of art and science: is personalized medicine getting personal enough?

Auteurs : Hendlisz A
Jaar : 2015
Journal : Curr Opin Oncol
Volume : 27(4)
Pagina's : 349-50

Erratum: Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.

Auteurs : Hendlisz A, Golfinopoulos V, Deleporte A, Paesmans M, El Mansy H, Garcia C, Peeters M, Annemans L, Vandeputte C, Maetens M, Van den Eynde M, Maréchal R, Borbath I, Dresse D, Houbiers G, Fried M, Awada A, Piccart-Gebhart M, Van Laethem JL, Flamen P
Jaar : 2015
Journal : BMC Cancer
Volume : 15
Pagina's : 173

Will modern immunotherapies become the standard of care for advanced synchronous or metachronous cancers?

Auteurs : Kourie HR, Awada A
Jaar : 2015
Journal : Future Oncol
Volume : 11
Pagina's : 3053-5

Participation of Italian Cancer Centres of the Alleanza Contro Il Cancro (ACC) in the Organisation of European Cancer Institutes (OECI) Accreditation and Designation program: a successful first national initiative.

Auteurs : Oberst S, Boomsma F, Lombardo C, Docter M, Blaauwgeers H, De Paoli P, de Valeriola D, Paradiso A, Saghatchian M
Jaar : 2015
Journal : Tumori
Volume : 101 Suppl 1
Pagina's : 0

Subclonal diversification of primary breast cancer revealed by multiregion sequencing.

Auteurs : Yates LR, Gerstung M, Knappskog S, Desmedt C, Gundem G, Van Loo P, Aas T, Alexandrov LB, Larsimont D, Davies H, Li Y, Ju YS, Ramakrishna M, Haugland HK, Lilleng PK, Nik-Zainal S, McLaren S, Butler A, Martin S, Glodzik D, Menzies A, Raine K, Hinton J, Jones D, Mudie LJ, Jiang B, Vincent D, Greene-Colozzi A, Adnet PY, Fatima A, Maetens M, Ignatiadis M, Stratton MR, Sotiriou C, Richardson AL, Lønning PE, Wedge DC, Campbell PJ
Jaar : 2015
Journal : Nat. Med.
Volume : 21(7)
Pagina's : 751-9

RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.

Auteurs : Azim HA, Peccatori FA, Brohée S, Branstetter D, Loi S, Viale G, Piccart-Gebhart M, Dougall WC, Pruneri G, Sotiriou C
Jaar : 2015
Journal : Breast Cancer Res
Volume : 17
Pagina's : 24

Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial.

Auteurs : Sonnenblick A, Brohée S, Fumagalli D, Rothé F, Vincent D, Ignatiadis M, Desmedt C, Salgado R, Sirtaine N, Loi S, Neven P, Loibl S, Denkert C, Joensuu H, Piccart-Gebhart M, Sotiriou C
Jaar : 2015
Journal : Oncotarget
Volume : 6
Pagina's : 30306-16

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.

Auteurs : Ignatiadis M, Lee M, Jeffrey SS
Jaar : 2015
Journal : Clin Cancer Res
Volume : 21
Pagina's : 4786-800

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial.

Auteurs : Salgado R, Denkert C, Campbell C, Savas P, Nucifero P, Aura C, de Azambuja E, Eidtmann H, Ellis CE, Baselga J, Piccart-Gebhart M, Michiels S, Bradbury I, Sotiriou C, Loi S
Jaar : 2015
Journal : JAMA Oncol
Volume : 1(4)
Pagina's : 448-54

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

Auteurs : Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F, + collaborators (among others :, Dal Lago L, de Azambuja E, Dabakuyo-Yonli TS
Jaar : 2015
Journal : Ann Oncol
Volume : 26(5)
Pagina's : 873-879.

Adult onset asynchronous multifocal eosinophilic granuloma of bone: an 11-year follow-up.

Auteurs : Dallaudière B, Kerger J, Malghem J, Galant C, Lecouvet FE
Jaar : 2015
Journal : Acta Radiol Open
Volume : 4(2)
Pagina's : 2047981614552217

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome.

Auteurs : Fumagalli D, Gacquer D, Rothé F, Lefort A, Libert F, Brown D, Kheddoumi N, Shlien A, Konopka T, Salgado R, Larsimont D, Polyak K, Willard-Gallo K, Desmedt C, Piccart-Gebhart M, Abramowicz M, Campbell PJ, Sotiriou C, Detours V
Jaar : 2015
Journal : Cell Rep
Volume : 13
Pagina's : 277-89